PolarityTE, Inc. (PTE)

1.5200 +0.0700 (+4.83%) At close: 04:00PM EDT

PolarityTE, Inc.

1960 South 4250 West
Salt Lake City, UT 84104
United States
800 560 3983
https://www.polarityte.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 59

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Richard Hague	Pres & CEO	649.26k	N/A	1960
Mr. Cameron J. Hoyler J.D.	Gen. Counsel, Sec., EVP of Corp. Devel. & Strategy and Chief Compliance Officer	623.19k	N/A	1984
Mr. Jacob Alexander Patterson	Chief Financial Officer	N/A	N/A	1979
Mr. Nikolai Sopko	Chief Scientific Officer and VP of R&D	N/A	N/A	N/A
Mr. Rich Haerle	VP of Investor Relations & Strategy	N/A	N/A	N/A
Angela Ziegler	VP of Marketing & PR	N/A	N/A	N/A
Mr. Alain Adam	VP of Sales	N/A	N/A	N/A
Dr. Stephen Milner M.D., DDS, DSc, FRCSE, FACS	Chief Clinical Officer & Member of Clinical Advisory Board	N/A	N/A	1949
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.	Sr. VP of Corp. Devel. & Pres of Contract Services	N/A	N/A	1963
Mr. Ryan Mathis M.D.	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Corporate Governance

PolarityTE, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.